News release: Renishaw drug delivery system to be used in Parkinsons trial (docx)

  • Download file
  • File size: 45 kB
  • Language: English

This type of file requires a viewer, freely available from Microsoft

Renishaw’s novel drug delivery system, to be used in partnership with Herantis Pharma Plc’s drug candidate CDNF for the treatment of Parkinson’s disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

Part number: H-4149-0098